Key Highlights

• Morgan Stanley Europe SE filed a Form 38.5(a) (EPT/RI) dealing disclosure on DCC plc (LSE:DCC) under the Irish Takeover Rules.

• The connected party is identified as an Energy Capital Partners, LLC and Kohlberg Kravis Roberts & Co. L.P. (ECP/KKR) consortium.

• The disclosed dealings on 1 June 2026 were modest: a purchase of 917 shares and a sale of 917 shares, with no derivatives.

• Prices ranged between roughly 59.60 and 60.00 GBP per share, reflecting DCC's high share price.

• The filing illustrates a possible private-equity take-private interest theme — but it discloses only small agency dealing and no offer terms.

Introduction

Private-equity interest in large, London-listed companies has become one of the defining themes of the UK stock market in recent years, and a fresh RNS announcement touching DCC plc (LSE:DCC) brings that theme into focus. On 2 June 2026, Morgan Stanley Europe SE published a Form 38.5(a) dealing disclosure in respect of DCC, covering dealings on 1 June 2026 and identifying the connected party as an Energy Capital Partners, LLC and Kohlberg Kravis Roberts & Co. L.P. consortium.

This article uses that filing as a starting point to explore, in careful and general terms, what private-equity interest in a FTSE 100 services group could mean for shareholders and how it fits the broader UK take-private trend. At the same time, it is important to be clear-eyed about the document itself: this particular disclosure records only modest agency dealing — 917 shares each way — and contains no offer price, terms or outcome. The wider theme is worth examining, but it must not be confused with anything the form actually confirms.

DCC plc (LSE:DCC): Company Background

DCC plc is a FTSE 100 international sales, marketing and support services group with Irish heritage and a primary London listing. It operates through three divisions: DCC Energy, focused on the sale, distribution and servicing of energy products and solutions; DCC Healthcare, serving the health and beauty markets; and DCC Technology, distributing and supporting technology products.

This diversified, services-led model has historically provided DCC with broad exposure across geographies and end-markets, underpinned by a long-standing reputation for disciplined capital allocation and acquisition-led growth. Among UK shares, DCC is one of the more internationally diversified names, and its cash-generative character has made it a durable constituent of the UK stock market's leading index.

It is precisely this profile — diversified, cash-generative and services-led — that tends to feature in discussions about which London-listed companies might attract financial-sponsor interest. That backdrop is useful context for understanding why a private-equity consortium might appear in a dealing disclosure, though, as always, the facts of any situation are determined by formal disclosures rather than by background characteristics.

What the RNS Announcement Says: Plain-English Summary

The announcement is a Form 38.5(a) (EPT/RI), the Irish Takeover Rules dealing disclosure used by a connected exempt principal trader with recognised intermediary status. The exempt principal trader is Morgan Stanley Europe SE, the offeree is DCC plc, and the party with which Morgan Stanley Europe is connected is identified as the Energy Capital Partners, LLC and Kohlberg Kravis Roberts & Co. L.P. consortium.

The dealings are dated 1 June 2026 and the disclosure was published on 2 June 2026, in DCC 0.25 ordinary shares. The dealing detail is modest: a purchase of 917 shares at a high of 59.8021 GBP and a low of 59.6000 GBP, and a sale of 917 shares at a high of 60.0000 GBP and a low of 59.6000 GBP. No derivative transactions are disclosed. The named contact is Claire Gordon.

What the form does not say is central to interpreting it correctly. It does not state any offer price, deal value, premium or terms. It does not confirm that the consortium has made or will make a firm offer, and it does not indicate any outcome. The prices, in the high 59s to 60.00 GBP per share, reflect DCC's status as a high-priced share. In short, the form confirms a connection and discloses small, two-way agency dealing — nothing more.

The Most Important Details

The most important thing to grasp about this filing is the contrast between its thematic significance and its literal content. Thematically, it adds another data point to the picture of an Energy Capital Partners and KKR consortium being connected with DCC during its offer period. Literally, it discloses only a purchase of 917 shares and a sale of 917 shares — equal and offsetting in quantity — with no derivatives.

That symmetry is characteristic of routine client-serving activity by an exempt principal trader. Morgan Stanley Europe SE is acting in a recognised intermediary capacity, not building a principal stake. The small size of the dealing, and the fact that the purchase and sale are identical in quantity, reinforce that this is ordinary agency flow rather than directional positioning by the consortium.

The connection to a named ECP/KKR consortium is nonetheless meaningful as part of the public record of the offer period. It tells investors which sponsors are connected with the dealing on this form. But the modest dealing detail is a reminder that the substance of any potential transaction is not contained in a Form 38.5(a) — only the dealing mechanics and the connection are.

Why Investors May Be Watching DCC plc (LSE:DCC)

Investors may be watching DCC (LSE:DCC) because the involvement of well-known financial sponsors in an offer period naturally draws attention, especially against the backdrop of a broader trend of private-equity bids for UK-listed companies. Shareholders following their investor update routine will note that an ECP/KKR consortium is identified as the connected party in dealing disclosures during this period.

However, interest must be tempered by precision. This particular form discloses only 917 shares bought and 917 shares sold, in a client-serving capacity, and contains no offer terms. It would be a significant overreach to treat such modest agency dealing as evidence of an imminent or agreed transaction. The form confirms a connection, not a deal.

The constructive perspective is that the Irish Takeover Rules are delivering transparency, allowing all shareholders to see the dealings of connected intermediaries during a sensitive period. For the substance of any potential take-private or other transaction, the authoritative sources are the formal RNS announcements from DCC and from the consortium, not the dealing forms of connected intermediaries.

Market Context

The UK stock market has experienced a notable wave of interest from private-equity and infrastructure investors in London-listed companies, a trend often described as the UK take-private theme. Lower relative valuations of some UK shares, combined with the substantial capital held by global sponsors, have contributed to a steady flow of approaches and completed transactions across the market in recent years.

Within this context, the appearance of an Energy Capital Partners and KKR consortium connected with dealing disclosures on DCC fits a recognisable pattern of sponsor interest in cash-generative, diversified businesses. The Irish Takeover Rules, applicable given DCC's Irish incorporation, and the broader transparency expectations of a primary London listing, ensure that such offer periods are accompanied by extensive disclosure — including EPT/RI filings such as this one from Morgan Stanley Europe.

This market context does not imply any particular DCC share price outlook. The take-private theme is a general market phenomenon; its presence does not guarantee that any specific transaction will occur at DCC, nor on any particular terms. The share price during an offer period reflects the credibility and terms of any offer, the company's fundamentals, and overall market conditions.

Industry Context

DCC's three divisions operate across distinct industries. Energy distribution and services are shaped by demand patterns, the energy transition and regulation — themes of particular relevance to an energy-focused investor such as Energy Capital Partners. Healthcare services follow health and beauty market trends, and technology distribution depends on product cycles and channel demand.

For financial sponsors, diversified and cash-generative services groups can be attractive because they offer relatively stable cash flows and potential avenues for operational value creation. The pairing of an energy and infrastructure specialist with a large global private-equity firm is consistent with interest in a group that has a meaningful energy distribution footprint, although the form provides no rationale and none should be assumed beyond the disclosed facts.

For investors considering the industry backdrop, the key point is that DCC's operating businesses continue to function across energy, healthcare and technology irrespective of corporate-activity speculation. Their performance will remain central to any assessment of the company under any ownership outcome.

Potential Opportunities

In general terms, private-equity interest in a listed company can introduce the possibility of corporate change, and the transparency provided by dealing disclosures helps shareholders follow the landscape of an offer period. The Morgan Stanley Europe filing contributes to that transparency by confirming the consortium connection and disclosing the related dealing, however modest.

For those assessing DCC (LSE:DCC) on fundamentals, the longer-term considerations remain the strength of its energy, healthcare and technology divisions, its capital discipline and its cash generation. These attributes are relevant under any ownership scenario and exist independently of the dealing form.

It is essential, however, to avoid translating the broad take-private theme, or a small agency dealing disclosure, into an assumption of a successful or value-accretive offer. The form discloses no terms and no outcome. Any genuine opportunity assessment must rest on the company's fundamentals and on the formal disclosures that would set out the substance of any transaction.

Key Risks and Uncertainties

The principal uncertainty is that this Form 38.5(a) confirms a consortium connection and discloses only small, offsetting agency dealing — it reveals nothing about offer terms or outcome. There is no disclosed bid price, no deal value and no confirmation that the ECP/KKR consortium has made or will make a firm offer, or that any offer would succeed. Drawing deal conclusions from such a filing would be unwarranted.

The UK take-private trend, while real, is also no guarantee for any individual company. Approaches can be made and withdrawn; potential offers can be subject to financing, due diligence, regulatory and competition considerations, and ultimately to board and shareholder decisions. Consortia can change in composition. The DCC share price during an offer period may be volatile and sentiment-driven, and the flow of dealing disclosures is not a reliable predictor of outcome.

The underlying business risks also remain: demand cycles across energy, healthcare and technology distribution, integration and execution risk, currency exposure and macroeconomic conditions. These continue to apply and should feature in any balanced view of DCC, independent of takeover speculation.

What Could Move the Share Price Next

Several developments could shape sentiment around DCC (LSE:DCC). The most material would be any formal RNS announcement clarifying whether the ECP/KKR consortium has made a firm offer and on what terms. Such announcements — not intermediary dealing forms — would carry the substance of any potential take-private or other transaction, including any conditions.

Further dealing disclosures, including additional EPT/RI filings, are likely to continue throughout the offer period and support transparency without, in themselves, signalling direction. Statements from the DCC board, any Takeover Panel timetable milestones, the company's trading performance, and the broader appetite of private-equity investors for UK-listed assets would all be relevant.

This article does not predict the direction of the DCC share price, and no reader should infer one from a dealing disclosure or from the general take-private theme. The disciplined approach is to follow the complete sequence of official disclosures and to assess each on its own factual basis.

Long-Term Outlook

Over the long term, DCC's prospects will continue to be driven by the performance of its energy, healthcare and technology divisions, its capital allocation and its cash generation. These fundamentals will endure regardless of how the current offer period, and any consortium interest, ultimately resolves.

The broader UK take-private trend may keep diversified, cash-generative groups like DCC in the conversation about potential sponsor interest, but a theme is not an outcome. The possibility remains that no firm offer emerges on terms some might expect. Whatever happens, the long-term investment case for DCC will rest on its operating businesses and strategic execution, not on the mechanics of any single dealing disclosure.

For now, the Morgan Stanley Europe Form 38.5(a) is best understood as a small, transparent piece of a larger picture: it confirms a consortium connection and discloses modest client-serving dealing, but it is silent on offer terms. That measured reading is the right one.

Conclusion

The Morgan Stanley Europe Form 38.5(a) on DCC plc (LSE:DCC) is a small but illustrative entry in the public record of DCC's offer period. It confirms that Morgan Stanley Europe is connected with an Energy Capital Partners and KKR consortium and discloses modest, offsetting client-serving dealings — 917 shares bought and 917 sold on 1 June 2026 — with no derivatives and no offer terms.

For investors following UK shares, FTSE stocks and the wider UK stock market, the filing is a useful prompt to consider the broader private-equity and take-private themes shaping the London Stock Exchange. But it is essential to keep theme and fact separate: this disclosure confirms a consortium connection and routine dealing, not an offer, terms or an outcome. The substance of any transaction will be set out in formal RNS announcements from DCC and the consortium — and that is where investors should look, while reading the original filing in full and avoiding premature conclusions about the share price outlook.